About Us

Formulated by Dr. Fred D. Sancilio

Omega blu™ is the result of over30 years of development

Omega blu™ products are designed to provide the best, most-effective vitamins and nutrients in optimal amounts.

In the 1990s, Dr. Sancilio owned and operated one of the largest drug research companies in the world. When Norwegian fishing industry executives visited him at his lab, they presented data that would ultimately lead to the development of a prescription omega-3 called Lovaza. The data showed that concentrated omega-3 could be used to treat various diseases and soon the US FDA would agree and approve Lovaza as a prescription drug.

Using this knowledge and 30 years of subsequent discoveries, he designed several brands of omega-3s and various other products that are currently marketed in the United States and around the world.

Dedicated to new developments

Meet the founder

After many years spent in drug research, in early January 2018, Dr. Sancilio and his wife Alex Sancilio founded a subsidiary of Sancilio called Clearway Global, Inc., a consulting and product development company located in Stuart, Fl. They focus on research and development work in such areas as sickle cell disease and dementia. They are also involved in advising several international pharmaceutical companies and are leading the development of several new drug candidates for the treatment of Alzheimer’s dementia, Traumatic Brain Injury, ALS, and Covid-19 infections.

In July 2019, Dr. Sancilio accepted a position as a Research Professor at Florida Atlantic University, Boca Raton, Fl. Through his efforts, the University has established a curriculum that teaches students aspects of drug development and research to better prepare them for an industrial career.

Third-party tested for premium quality

Sustainable products backed by science